Wake Forest University Baptist Medical Center

Oncology & Cancer

Set of genetic markers in lung cancer identified

Investigators at Wake Forest School of Medicine, part of Wake Forest Baptist Health, have identified a set of new genetic markers that could potentially lead to new personalized treatments for lung cancer.

Oncology & Cancer

Changing cancer care, one organoid at a time

A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine (WFIRM) researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments. ...

page 12 from 31